MedTrace Logo

Effect of Outpatient Symptom Management on Gynecologic Oncology Patients Receiving Chemotherapy

NCT02786524 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 107

Last updated 2019-03-21

No results posted yet for this study

Summary

To evaluate whether formal referral to The Symptom Management and Supportive Care Clinic improves symptom burden in advanced stage or recurrent gynecologic oncology chemotherapy patients compared with symptom management performed by the primary gynecologic oncologist.

Conditions

  • Uterine Cervical Neoplasms
  • Ovarian Neoplasms
  • Gynecologic Neoplasms
  • Fallopian Tube Neoplasms
  • Vulvar Neoplasms
  • Vaginal Neoplasms
  • Peritoneal Neoplasms

Interventions

BEHAVIORAL

Specialized Symptom Management and Supportive Care

Based on Patients who score 5 or higher on the Baseline Patient Palliative Care Survey that will identify patients that will most benefit from specialty palliative care

Sponsors & Collaborators

Principal Investigators

  • Katherine Harris, MD · University of Michigan

  • Carolyn M Johnston, MD · University of Michigan

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-02-15
Primary Completion
2017-10-31
Completion
2017-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02786524 on ClinicalTrials.gov